Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The integration of psychiatry with neuroscience, biochemistry, and genetics

Mark Rubinstein, MD
Conditions
October 11, 2016
Share
Tweet
Share

As a forensic psychiatrist, I have testified in courtrooms, at depositions, legal hearings, and inquests. I’ve been cross-examined by attorneys whose agenda was to discredit my testimony or demean psychiatry as a medical specialty. Two criticisms frequently leveled at psychiatry are: 1) Psychiatry has not changed significantly for the last sixty years and, 2) Psychiatry is the least scientific of all medical specialties.

These beliefs are not true.

Over the last few decades, psychiatry as a medical specialty has changed dramatically.

Over the last sixty years, more advances have been made in understanding and treating mental illness than in all the centuries during which human beings have populated the earth. Even newer developments will change nearly everything about psychiatric treatment. Psychiatry as a medical specialty is on the cusp of profound scientific breakthroughs, and the specialty has entered the realm of neuroscience. With the latest developments, psychiatry can no longer be viewed strictly as a social science or the handmaiden of medicine.

Beginning in the late 1980s, effective medications were developed, including potent antipsychotic remedies, effective antidepressants, anti-anxiety medications, and mood stabilizers. These medications have transformed formerly untreatable conditions such as phobias, panic disorder, PTSD, and depression. The latest generation of SSRI and SNRI medications effectively smother symptoms of these disorders and have changed the landscape of clinical practice. New mood stabilizers have made bipolar disorder eminently treatable, and people so afflicted can lead normal lives. The latest neuroleptic medications have few side effects and suffocate symptoms of schizophrenia.

Innovative treatments have evolved, including light therapy, transcranial magnetic stimulation, sophisticated neuroimaging, and much more advanced techniques for administering electroconvulsive therapy.

More innovations are on the way.

Psychiatry is now on the cusp of revolutionary new developments. These include the potential for gene therapy and the discovery of new biological markers for many illnesses. Neurobiological markers for schizophrenia, bipolar disorder, and other major psychiatric conditions have been discovered. These advances implicate specific brain pathways and chemical neurotransmitters as playing crucial roles in various forms of psychopathology. Neuroimaging of the brain has evolved whereby specific structural abnormalities are observed and monitored for psychiatric illnesses.

Certain predictive drug-related biomarkers will soon be used to indicate whether one specific medication or another will be most effective for an individual. There will be no more trial-and-error treatment for depression or schizophrenia.

In the not-too-distant future, biomarkers will make it possible to prevent the onset of mental illness and will be used to individually tailor treatments for those already affected. Within our lifetimes, a simple blood test to determine a person’s genome will be used in gene therapy. Imagine this: A blood sample drawn from an infant will be able to determine a minute genetic variation responsible for the onset of a specific psychiatric disorder later in life. Altering that genetic configuration will allow physicians to eradicate that psychopathology either before it arises or after it has achieved expression.

And, these new developments do not discount the benefits patients derive from supportive counseling or insight-oriented psychotherapy. In fact, for psychotherapy to be effective, it must work through biological mechanisms. Many neuroimaging studies have demonstrated that psychotherapy itself affects demonstrable brain changes, impacting certain brain areas as profoundly as medication, electroconvulsive therapy, and deep brain stimulation.

The integration of psychiatry with neuroscience, biochemistry and genetics has already begun. This development will have a profound impact on human suffering and well-being far into the future.

Mark Rubinstein is a psychiatrist and author of Bedlam’s Door: True Tales of Madness and Hope.

Image credit: Shutterstock.com

ADVERTISEMENT

Prev

The honest reasons why this doctor chose internal medicine

October 11, 2016 Kevin 4
…
Next

Watch this inspiring journey of an orthopedic resident

October 11, 2016 Kevin 0
…

Tagged as: Psychiatry

Post navigation

< Previous Post
The honest reasons why this doctor chose internal medicine
Next Post >
Watch this inspiring journey of an orthopedic resident

ADVERTISEMENT

More by Mark Rubinstein, MD

  • Where money and the law intersect, truth can sometimes be the victim

    Mark Rubinstein, MD
  • The psychiatrist as a double agent

    Mark Rubinstein, MD

Related Posts

  • Scenes from a medical student’s rotation in psychiatry

    Natalia Birgisson
  • Why a prison psychiatry rotation should be mandatory for all medical students

    Tiana Walker
  • Doctor, how are you, really?

    Deborah Courtney
  • Why aren’t you treating opioid addiction?

    Kathleen A. Hallinan, MD
  • Treating mental illness will not stop mass shootings

    M. Bennet Broner, PhD
  • 5 things America can do today to reduce gun deaths

    Megan L. Ranney, MD, MPH

More in Conditions

  • Is direct primary care sustainable in a downturn?

    Dana Y. Lujan, MBA
  • How movement improves pelvic floor function

    Martina Ambardjieva, MD, PhD
  • How immigrant physicians solved a U.S. crisis

    Eram Alam, PhD
  • Pediatric leadership silence on FDA ADHD recall

    Ronald L. Lindsay, MD
  • The ethical conflict of the Charlie Gard case

    Timothy Lesaca, MD
  • The ethics of mandatory Tay-Sachs testing

    Sheryl J. Nicholson
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Aging parents and Thanksgiving: a gentle check-in

      Barbara Sparacino, MD | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • Trauma in high-functioning adults

      Ronke Lawal | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
  • Recent Posts

    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Is direct primary care sustainable in a downturn?

      Dana Y. Lujan, MBA | Conditions
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Transforming patient fear into understanding through clear communication [PODCAST]

      The Podcast by KevinMD | Podcast
    • How movement improves pelvic floor function

      Martina Ambardjieva, MD, PhD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Aging parents and Thanksgiving: a gentle check-in

      Barbara Sparacino, MD | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • Trauma in high-functioning adults

      Ronke Lawal | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
  • Recent Posts

    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Is direct primary care sustainable in a downturn?

      Dana Y. Lujan, MBA | Conditions
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Transforming patient fear into understanding through clear communication [PODCAST]

      The Podcast by KevinMD | Podcast
    • How movement improves pelvic floor function

      Martina Ambardjieva, MD, PhD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The integration of psychiatry with neuroscience, biochemistry, and genetics
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...